Amakuru y'ibanze
izina RY'IGICURUZWA | Cataloge | Andika | Umucumbitsi / Inkomoko | Ikoreshwa | Porogaramu | COA |
HCV Core-NS3-NS5 fusion antigen | BMGHCV101 | Antigen | Ecoli | Gufata | LF, IFA, IB, WB | Kuramo |
HCV Core-NS3-NS5 fusion antigen | BMGHCV102 | Antigen | Ecoli | Conjugate | LF, IFA, IB, WB | Kuramo |
Abenshi mu barwayi nta bimenyetso bigaragara bafite mu cyiciro gikaze cyo kwandura, biherekejwe na virusi nyinshi ndetse no kuzamuka kwa ALT.HCV RNA yagaragaye mumaraso hakiri kare kuruta anti HCV nyuma yo kwandura gukabije kwa HCV.HCV RNA irashobora kumenyekana nyuma y'ibyumweru 2 nyuma yo kumenyekana hakiri kare, antigen yibanze ya HCV irashobora kumenyekana nyuma yiminsi 1 kugeza kuri 2 nyuma yuko HCV RNA igaragaye, kandi anti HCV ntishobora kumenyekana kugeza ibyumweru 8 kugeza 12, ni ukuvuga ko nyuma y’ubwandu bwa HCV, hari ibyumweru bigera kuri 8-12, gusa HCV RNA irashobora kuboneka, mugihe anti HCV ari mbi, ni ukuvuga "igihe cyidirishya" cyo kumenya "idirishya".Anti HCV ntabwo ari antibody ikingira, ahubwo ni ikimenyetso cyanduye HCV.15% ~ 40% by'abarwayi bafite virusi ikaze ya HCV barashobora gukuraho ubwandu mu mezi 6.Mu gihe cyo gukuraho ubwandu, urwego rwa HCV RNA rushobora kuba ruto cyane ku buryo rutamenyekana, kandi kurwanya HCV gusa ni byiza;Nyamara, 65% ~ 80% by'abarwayi ntibamaze amezi 6 bakuweho, aribyo bita infection idakira ya HCV.Iyo hepatite C idakira imaze kubaho, titre ya HCV RNA itangira guhagarara neza, kandi gukira bidatinze ni gake.Keretse niba hakozwe imiti igabanya ubukana bwa virusi, ntibikunze kubaho gukuraho HCV RNA.Mubikorwa byubuvuzi, abarwayi benshi barwaye hepatite C idakira bafite amahirwe yo kurwanya HCV (abarwayi badafite ubudahangarwa, nk'abanduye virusi itera sida, abahawe transplant transplant, abarwayi bafite hypogammaglobulinemia cyangwa abarwayi ba hemodialysis bashobora kuba babi kuri anti HCV), kandi HCV RNA irashobora kuba nziza cyangwa mbi (urwego rwa HCV RNA ruri hasi nyuma yo kwivuza virusi).